| Properties | Information | |
|---|---|---|
| PhytoCAT-ID | PhytoCAT-228 | |
| Phytochemical name or plant extracts | Artemisia biennis extract | |
| PMID | 21592012 | |
| Literature evidence | Artemisia could be also considered as a promising chemotherapeutic agent in cancer treatment. | |
| IUPAC name | NA | |
| Phytochemicals’ class or type of plant extracts | Methanolic extract, Ethyl acetate extract, Dichloromethane extract, n-Hexane extract | |
| Source of phytochemicals or plant Extracts | Artemisia biennis | |
| Geographical availability | Alaska, Alberta, Arizona, British Columbia, California, Colorado, Idaho, Montana, Nevada, New Mexico, Northwest Territorie, Oregon, Utah, Washington, Wyoming, Yukon | |
| Plant parts | Aerial parts | |
| Other cancers | Breast cancer, Stomach cancer, Cervical cancer, Colon cancer | |
| Target gene or protein | NA | |
| Gene or Protein evidence | NA | |
| Target pathways | NA | |
| IC50 | Methanol extract - 451 µg/ml against MCF-7 Ethyl acetate extract - 1224 µg/ml against MCF-7 Dichloromethane extract - 451 µg/ml against MCF-7 n-Hexane extract - 338 µg/ml against MCF-7 | |
| Potency | NA | |
| Cell line/ mice model | AGS, HeLa, HT-29, MCF-7 | |
| Additional information | NA | |
| PubChem ID | NA | |
| Additional PMIDs | NA | |
| Additional sources of information | https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:305619-2 | |
| Safety | NA |